Maag Peter's Form 4 filing
CareDx, Inc. (CDNA) · filed Dec 7, 2021
- Accession no.
- 0001217234-21-000253
- Filed
- Dec 7, 2021
- Trade date
- Dec 6, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $416.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maag PeterCIK 0001613855 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Common Stock | MOption exerciseAcquired | +926 | $6.31 | +$5,843.06 | 342,682 | Direct | |
| Dec 6, 2021 | Common Stock | MOption exerciseAcquired | +3,125 | $12.24 | +$38,250 | 345,807 | Direct | |
| Dec 6, 2021 | Common Stock | MOption exerciseAcquired | +5,949 | $24.35 | +$144,858.15 | 351,756 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −6,588 | $41.30F2 | −$272,084.4 | 345,168 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −3,112 | $42.20F3 | −$131,326.4 | 342,056 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −300 | $42.61F4 | −$12,783 | 341,756 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Common Stock | MOption exerciseDisposed | −926 | $0.00 | $0 | 7,090 | Direct | |
| Dec 6, 2021 | Common Stock | MOption exerciseDisposed | −3,125 | $0.00 | $0 | 18,750 | Direct | |
| Dec 6, 2021 | Common Stock | MOption exerciseDisposed | −5,949 | $0.00 | $0 | 45,007 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.56 to $41.54, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.57 to $42.55, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $42.625, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.